New Key Statistics Module, Z-Score and F-Score
NYSE:GSK Key Ratios
Market Cap $ M | 85,571.05 |
Enterprise Value $ M | 101,071.26 |
P/E(ttm) | 14.83 |
PE Ratio without NRI | 13.52 |
Forward PE Ratio | 10.56 |
Price/Book | 5.04 |
Price/Sales | 2.34 |
Price/Free Cash Flow | 15.95 |
Price/Owner Earnings | 11.97 |
Payout Ratio % | 0.46 |
Revenue (TTM) $ M | 37,774.00 |
EPS (TTM) $ | 2.78 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | 4.90 |
EV-to-EBIT | 12.01 |
EV-to-EBITDA | 8.97 |
PEG | 13.52 |
Shares Outstanding M | 2,072.44 |
Net Margin (%) | 16.25 |
Operating Margin % | 24.22 |
Pre-tax Margin (%) | 20.00 |
Quick Ratio | 0.62 |
Current Ratio | 0.88 |
ROA % (ttm) | 8.27 |
ROE % (ttm) | 40.01 |
ROIC % (ttm) | 12.70 |
Dividend Yield % | 3.58 |
Altman Z-Score | 1.89 |
GSK Number of Guru Trades
GSK Volume of Guru Trades
Gurus Latest Trades with NYSE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:GSK is held by these investors
Total 7
GSK PLC Insider Transactions
No Available Data
News about NYSE:GSK
Total 0- 1